Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Androgen Receptor-Directed Molecular Conjugates for Targeting Prostate Cancer
Giovanni Luca Beretta, Nadia Zaffaroni
Frontiers in Chemistry (2019) Vol. 7
Open Access | Times Cited: 19

Showing 19 citing articles:

Metabolic Plasticity in Chemotherapy Resistance
María Andrea Desbats, Isabella Giacomini, Tommaso Prayer‐Galetti, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 136
An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer
Michael L. Mohler, Arunima Sikdar, Suriyan Ponnusamy, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2124-2124
Open Access | Times Cited: 54
Current Status and Future Perspectives of Androgen Receptor Inhibition Therapy for Prostate Cancer: A Comprehensive Review
Tae Jin Kim, Young Hwa Lee, Kyo Chul Koo
Biomolecules (2021) Vol. 11, Iss. 4, pp. 492-492
Open Access | Times Cited: 35
Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
Daisuke Obinata, Mitchell G. Lawrence, Ken‐ichi Takayama, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 34
miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer
Noemi Arrighetti, Giovanni Luca Beretta
Pharmaceutics (2021) Vol. 13, Iss. 3, pp. 380-380
Open Access | Times Cited: 32
Targeted Degradation of Androgen Receptor by VNPP433-3β in Castration-Resistant Prostate Cancer Cells Implicates Interaction with E3 Ligase MDM2 Resulting in Ubiquitin-Proteasomal Degradation
Elizabeth Thomas, Retheesh S. Thankan, Puranik Purushottamachar, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1198-1198
Open Access | Times Cited: 11
Management of men with metastatic castration-resistant prostate cancer following potent androgen receptor inhibition: a review of novel investigational therapies
Matthew Labriola, Saad Omar Atiq, Nathan Hirshman, et al.
Prostate Cancer and Prostatic Diseases (2020) Vol. 24, Iss. 2, pp. 301-309
Closed Access | Times Cited: 29
Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1
James E. Melnyk, Veronica Steri, Hao G. Nguyen, et al.
Oncogene (2022) Vol. 41, Iss. 11, pp. 1536-1549
Open Access | Times Cited: 13
Chemical Tagging of Bioactive Amides by Cooperative Catalysis: Applications in the Syntheses of Drug Conjugates
Cunyuan Zhao, Yuan-Kai Wang, Quan Pham, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 26, pp. 14233-14250
Open Access | Times Cited: 7
Identification of key genes and multiple molecular pathways of metastatic process in prostate cancer
Lihuang Guo, Mingyue Lin, Zhenbo Cheng, et al.
PeerJ (2019) Vol. 7, pp. e7899-e7899
Open Access | Times Cited: 18
The role of ubiquitination in spinal and bulbar muscular atrophy
Medha Sengupta, Anna Pluciennik, Diane E. Merry
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 9
Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer Cells
Sergey A. Dyshlovoy, Dmitry N. Pelageev, Lea S. Jakob, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 949-949
Open Access | Times Cited: 10
Design, Synthesis, and Biological Evaluation of Androgen Receptor Degrading and Antagonizing Bifunctional Steroidal Analogs for the Treatment of Advanced Prostate Cancer
Ao Wang, Xianggang Luo, Yawan Wang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 18, pp. 12460-12481
Closed Access | Times Cited: 6
Serum Lactate Dehydrogenase as a Potential Predictive Index of Chemotherapy Response in Breast Cancer Patients

Health Sciences Investigations Journal (2024), Iss. Volume 5 Issue 1, pp. 654-659
Open Access
Advances in AR-targeting chimeras: a case study of proteolysis-targeting chimeras from bench to bedside
Wu Du
Future Medicinal Chemistry (2022) Vol. 14, Iss. 20, pp. 1471-1489
Closed Access | Times Cited: 2
Two Phenolic Compounds (Biscoumarin and Biflavonoid) From Ormocarpum kirkii S. Moore (Fabaceae) Exhibit Anticancer Properties Against Human Prostate Cancer Cells
Eutrophe Le Doux Kamto, Stéphane Zingue, Timothy Grein, et al.
Journal of Herbal Medicine (2023) Vol. 42, pp. 100811-100811
Closed Access
Computational approaches to identify a novel binding site of BHPI on estrogen receptor alpha
Monica Bean, Reham A Alkohaif, Ahed Anbari, et al.
Steroids (2022) Vol. 186, pp. 109075-109075
Open Access
Stability of Steroid Hormone Receptors
Zachary J. Gale‐Day, Jason E. Gestwicki
(2022), pp. 27-64
Closed Access
Androgen metabolism in castration-resistant prostate cancer
Tomas Koltai, Stephan J. Reshkin, Fátima Baltazar, et al.
Elsevier eBooks (2021), pp. 339-368
Closed Access
Page 1

Scroll to top